Stay updated on Venetoclax & AMG 176 in Hematologic Malignancies Clinical Trial
Sign up to get notified when there's something new on the Venetoclax & AMG 176 in Hematologic Malignancies Clinical Trial page.

Latest updates to the Venetoclax & AMG 176 in Hematologic Malignancies Clinical Trial page
- ChecktodayNo Change Detected
- Check8 days agoNo Change Detected
- Check15 days agoChange DetectedAdded Revision: v3.5.0 and removed Revision: v3.4.3 in the study record history.SummaryDifference0.1%

- Check22 days agoNo Change Detected
- Check29 days agoChange DetectedRevision history updated: added v3.4.3, removed v3.4.2.SummaryDifference0.1%

- Check58 days agoChange DetectedA new revision entry v3.4.2 was added to the record history, and the government funding notice along with the v3.4.1 revision entry were removed.SummaryDifference0.8%

- Check65 days agoChange DetectedA government funding notice banner was added to the page. The revision history shows the version updated from v3.4.0 to v3.4.1.SummaryDifference0.8%

- Check72 days agoChange DetectedUI updates include a glossary toggle and color-coding explanations for changes, and the revision heading now shows v3.4.0 (replacing v3.3.4).SummaryDifference1%

- Check86 days agoChange DetectedA new revision entry v3.3.4 was added to the history, and the previous revision v3.3.3 was removed.SummaryDifference0.1%

Stay in the know with updates to Venetoclax & AMG 176 in Hematologic Malignancies Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Venetoclax & AMG 176 in Hematologic Malignancies Clinical Trial page.